美国食品药品监督管理局（FDA）周二警告安进公司，称其结直肠癌药物的一则宣传视频具有误导性，因为该视频突出强调了药物的益处，却未能充分披露严重的安全风险和患者限制。
The US FDA on Tuesday warned Amgen that a promotional video for its colorectal cancer drug was misleading because it highlighted the benefits while failing to adequately disclose serious safety risks and patient limitations.